113 related articles for article (PubMed ID: 6272171)
21. Mitogenic effect of 12-0 tetradecanoyl phorbol 13-acetate on non-human primate mononuclear cells and in vitro interaction with Epstein-Barr virus transformation.
Sundar SK; Ablashi DV; Bengali ZH; Levine PH; Nonoyama M
Arch Virol; 1980; 64(2):141-53. PubMed ID: 6247996
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by retinoids of platelet growth factor-dependent stimulation of DNA synthesis and cell division in density-arrested C3H 10T1/2 fibroblasts.
Mordan LJ
Cancer Res; 1989 Feb; 49(4):906-9. PubMed ID: 2783558
[TBL] [Abstract][Full Text] [Related]
23. Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: mutated p21 ras oncogene as a model.
Kubuschok B; Cochlovius C; Jung W; Schmits R; Trümper L; Hartmann F; Renner C; Pfreundschuh M
Cancer Gene Ther; 2000 Sep; 7(9):1231-40. PubMed ID: 11023195
[TBL] [Abstract][Full Text] [Related]
24. Interaction of herpesvirus ateles with marmoset lymphocytes. II. Identification of target cell population and stimulation of DNA synthesis after infection in vitro.
Johnson DR; Ernberg I; Klein G
Intervirology; 1980; 14(3-4):202-7. PubMed ID: 6263823
[No Abstract] [Full Text] [Related]
25. Interaction of Herpesvirus ateles and Hepesvirus saimiri with primate lymphocytes. I. Selective adsorption of virus by lymphoid cells.
Johnson DR; Klein G; Falk L
Intervirology; 1980; 13(1):21-7. PubMed ID: 6766914
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
Sundar SK; Levine PH; Ablashi DV; Menezes J
Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
[TBL] [Abstract][Full Text] [Related]
27. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
[TBL] [Abstract][Full Text] [Related]
28. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed, and tumor cells in vitro.
Lotan R; Nicolson GL
J Natl Cancer Inst; 1977 Dec; 59(6):1717-22. PubMed ID: 562945
[No Abstract] [Full Text] [Related]
30. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
[TBL] [Abstract][Full Text] [Related]
31. Lymphokines produced by herpesvirus-transformed marmoset monkey lymphoid cell lines. I. Characterization of a constitutively produced interferon.
Adolf GR
Virology; 1984 Aug; 137(1):195-200. PubMed ID: 6206645
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
Lau YL; Shields JG; Levinsky RJ; Callard RE
Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
[TBL] [Abstract][Full Text] [Related]
33. Decreased calcium dependence of lymphoblastoid cell lines compared with Burkitt lymphoma cell lines.
Parsons PG; Moss DJ; Morris C; Musk P; Maynard K; Partridge R
Int J Cancer; 1985 Jun; 35(6):743-7. PubMed ID: 2989188
[TBL] [Abstract][Full Text] [Related]
34. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
Meij P; Bloemena E; Palmen N; Brink A; Vervoort MB; Meijer CJ; Middeldorp JM
Cell Immunol; 2001 Feb; 208(1):25-33. PubMed ID: 11277616
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-transformed lymphoblastoid cell lines as antigen-presenting cells and "augmenting" cells for human CMV-specific Th clones.
Liu YN; Fuad S; Gehrz RC
Cell Immunol; 1987 Aug; 108(1):64-75. PubMed ID: 3038341
[TBL] [Abstract][Full Text] [Related]
36. Immune response to alien histocompatibility antigens on Epstein-Barr virus transformed cells.
Mori T; Koishi T; Fujii G; Ohsawa N
Jpn J Exp Med; 1982 Jun; 52(3):125-9. PubMed ID: 6290715
[TBL] [Abstract][Full Text] [Related]
37. Purification and biochemical characterization of an inhibitor of DNA synthesis produced by an Epstein-Barr virus-transformed B cell line.
Beneke JS; Qualtiere LF; Nesheim MC; Pearson GR
J Immunol; 1980 Jun; 124(6):2950-5. PubMed ID: 6246172
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of cell lines established from Epstein-Barr virus induced marmoset tumors.
Neubauer RH; Rabin H; Hopkins RF; Levy BM
Primates Med; 1978; 10():156-62. PubMed ID: 205853
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid inhibition of Epstein-Barr virus induction.
Yamamoto N; Bister K; zur Hausen H
Nature; 1979 Apr; 278(5704):553-4. PubMed ID: 219367
[No Abstract] [Full Text] [Related]
40. Combination of mutant EL-4 thymoma cells and EBV-infection in B lymphocyte activation a) EBV-infection of EL-4-activated lymphocytes. b) Use of EL-4 cells as feeders for lymphoblastoid cell lines.
Barcellini W; Borghi MO; Nicoletti F; Bonara P; Fain C; Meroni PL
J Clin Lab Immunol; 1990 Sep; 33(1):21-8. PubMed ID: 1966941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
